Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study

Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study

© 2019 The British Pharmacological Society Aims: Sodium glucose co-transporter-2 inhibitors have been shown to reduce cardiovascular events and heart failure in type 2 diabetic (T2D) patients with high cardiovascular risk. Dipeptidyl peptidase-4 inhibitors showed neutral effects and may increase ris...

Full description

Saved in:
Bibliographic Details
Main Authors: Arintaya Phrommintikul, Wanwarang Wongcharoen, Sirinart Kumfu, Thidarat Jaiwongkam, Siriluck Gunaparn, Siriporn Chattipakorn, Nipon Chattipakorn
Format: Journal
Published: 2019
Subjects:
Medicine
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064487765&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/65738
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064487765&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/65738

Similar Items